UBS expects supply-led CCL price increases and rising high-end AI CCL sales to lift Nan Ya Plastics' profitability sharply through 2027. Its NT$300.00 target is based on a sum-of-the-parts valuation.
- CCL ASP is forecast to rise 90% in 2026E and 85% in 2027E.
- CCL operating margin is projected to expand from 4.1% in 2025 to 23% in 2026E and 30% in 2027E.
- High-end M6+ CCL is forecast to reach 25% of CCL revenue in 2027E, with ASPs 3-10x conventional FR4.
- UBS forecasts 2026E/2027E net profit 15%/23% above consensus.
- The report argues that the market underappreciates NYP's core CCL earnings because of concerns over petrochemicals.